Frontlight ResearchEarly access
Metastatic breast cancer trials in United States
222 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
- Where
- Ann Arbor, Billings, Canton, Dallas, Denver, Duarte, Durham, Fairfax, Golden, Grand Junction, Houston, Jacksonville, La Jolla, Miami, New York, Omaha, Orange, Phoenix, Portland, Rochester, Saint Louis Park, Seattle, St Louis, Tampa, Tucson, Washington D.C., Zion
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- ALX Oncology Inc.
See details and how to joinNCT07007559 - No phaseTaking peopleInvestigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer
- Where
- Duarte
- Age
- 18 years and over
- People
- 160
- Run by
- City of Hope Medical Center
See details and how to joinNCT07664579 - No phaseNot yet taking people in United StatesTranscranial Direct Current Stimulation to Improve Gait for Breast Cancer Survivor's Who Received Taxene and/or Platinum Chemotherapy
- Where
- Ann Arbor
- Age
- 60 years to 85 years
- People
- 60
- Run by
- University of Michigan Rogel Cancer Center
See details and how to joinNCT07864792 - Phase 1/2Taking peopleA Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
- Where
- Chattanooga, Columbus, Duarte, Durham, Germantown, Hackensack, Howell Township, Irvine, La Jolla, Longmont, Los Angeles, Nashville, New Brunswick, New York, Omaha, Philadelphia, Pittsburgh, Plano, Reno, Saint Paul, Stanford, Tampa, Zion
- Age
- 18 years and over
- People
- 1,132 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT03424005 · EU 2023-503629-20-00 - Phase 2Taking peopleGene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
- Where
- Birmingham, Dallas, Memphis, Nashville
- Age
- 18 years and over
- People
- 64
- Run by
- Sonya Reid
See details and how to joinNCT05693766 - No phaseTaking peopleImproving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
- Where
- Houston, Philadelphia, San Diego, San Francisco
- Age
- 18 years and over
- People
- 150
- Run by
- University of California, San Francisco
See details and how to joinNCT05964504 - Phase 3Taking peoplePhase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
- Where
- Altamonte Springs, Ann Arbor, Atlanta, Austin, Baltimore, Beverly Hills, Boston, Chicago, Dallas, Duarte, Fairfax, Fort Myers, Gilbert, Hackensack, Houston, Indianapolis, Jackson, Knoxville, Longmont, Los Angeles, Madison, Minneapolis, Nashville, Newark, New Brunswick, New Haven, New York, Norfolk, Omaha, Palm Bay, Palo Alto, Portland, Reno, Royal Oak, Sacramento, Salt Lake City, San Diego, San Francisco, Sioux Falls, St Louis, Temple, Vallejo, Washington D.C., Westwood, Wichita
- Age
- 18 years and over
- People
- 540 worldwide
- Run by
- Relay Therapeutics, Inc.
See details and how to joinNCT06982521 · EU 2025-523083-21-00 - Phase 1Taking peopleA Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
- Where
- Conroe, Duarte, Grand Rapids, Houston, League City, Long Island City, New York, San Antonio, Sugar Land, West Valley City
- Age
- 18 years and over
- People
- 260 worldwide
- Run by
- Pfizer
See details and how to joinNCT07318805 · EU 2025-524387-38-00 - Phase 2/3Taking peopleRO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive
- Where
- Albany, Austin, Clovis, East Brunswick, Fort Worth, Germantown, Gilbert, Grand Rapids, Huntsville, Nashville, Norwich, Sacramento, San Francisco, Shirley, Stony Brook, The Bronx
- Age
- 18 years and over
- People
- 650 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07413939 · EU 2025-524498-17-00 - No phaseNot yet taking people in United StatesProspective Study to Evaluate the Clinical Utility of ctDNA Tumor Fraction (TF) for Detection of Estrogen Receptor 1 (ESR1) Mutations in (Human Epidermal Growth Factor Receptor) HR+/HER2- Metastatic Breast Cancer (MBC)
- Where
- New Haven
- Age
- 18 years and over
- People
- 155
- Run by
- Yale University
See details and how to joinNCT07910565 - No phaseTaking peopleCollecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Where
- Aberdeen, Aitkin, Akron, Albert Lea, Albuquerque, Allentown, Alma, Alpena, Alton, Amarillo, Ames, Anaconda, Anchorage, Anderson, Ankeny, Ann Arbor, Antigo, Appleton, Arroyo Grande, Asheville, Ashland, Augusta, Aurora, Aventura, Baker City, Bakersfield, Ballwin, Baltimore, Baraboo, Barberton, Bardstown, Barrington, Baton Rouge, Battle Creek, Baxter, Beavercreek, Belfast, Bellingham, Belpre, Bemidji, Bend, Berlin, Bethesda, Bethlehem, Biddeford, Billings, Bismarck, Bloomington, Boardman, Boise, Bolivar, Bonita Springs, Boone, Boulder, Bozeman, Brainerd, Branson, Braselton, Brewer, Brighton, Brownstown, Brunswick, Bryan, Burbank, Burien, Burlington, Burnsville, Caldwell, Cambridge, Canton, Cape Girardeau, Carbondale, Carmichael, Caro, Carson City, Carterville, Carthage, Cary, Cedar Rapids, Centennial, Centerville, Centralia, Chaska, Chelsea, Chesapeake, Chesterfield, Cheyenne, Chicago, Chillicothe, Cincinnati, Clackamas, Clarkston, Clearwater, Clinton, Clinton Township, Clive, Clyde, Cody, Coeur d'Alene, Colorado Springs, Columbia, Columbus, Concord, Coon Rapids, Coos Bay, Corbin, Council Bluffs, Creston, Crosslake, Crystal Lake, Cudahy, Danville, Dayton, Dearborn, Decatur, Deerfield Beach, Deer River, Delaware, Denver, Des Moines, Detroit, Detroit Lakes, Dixon, Downers Grove, Dublin, Duluth, Durango, Durham, East China Township, Easton, East Stroudsburg, Eau Claire, Edgewood, Edina, Edmonds, Effingham, Elgin, Elk Grove, Elmhurst, Elmira, Ely, Emeryville, Emmett, Englewood, Enumclaw, Eureka, Everett, Evergreen Park, Fairbanks, Fargo, Farmington, Farmington Hills, Federal Way, Findlay, Fishersville, Flint, Florence, Fond du Lac, Fort Collins, Fort Dodge, Fort Lauderdale, Fort Myers, Fort Smith, Fort Thomas, Fosston, Franklin, Freehold, Fridley, Fruitland, Gaffney, Gahanna, Gainesville, Galesburg, Garden City, Garner, Georgetown, Germantown, Gladwin, Glen Burnie, Glens Falls, Goldsboro, Grafton, Grand Forks, Grand Island, Grand Rapids, Great Bend, Great Falls, Greeley, Green Bay, Greenville, Greenwood, Greer, Grosse Pointe Woods, Grove City, Hackettstown, Harvey, Havre, Hayward, Hazel Crest, Hazleton, Helena, Henderson, Hendersonville, Hibbing, Hood River, Houma, Houston, Huntington, International Falls, Issaquah, Jackson, Jacksonville, Jamaica, Jamaica Plain, Jamestown, Janesville, Jefferson, Jefferson City, Joplin, Kalamazoo, Kalispell, Kansas City, Kearney, Kennewick, Kenosha, Kettering, Kewanee, Kingman, Lacey, La Crosse, Lakeland, Lakewood, Lancaster, Lansing, Laredo, Las Cruces, Las Vegas, Leavenworth, Lewisburg, Lexington, Libertyville, Lima, Lincoln, Little Rock, Littleton, Livonia, Loma Linda, London, Lone Tree, Long Beach, Longmont, Longview, Loveland, Macomb, Madison, Manchester, Mankato, Mansfield, Maple Grove, Maplewood, Marietta, Marinette, Marion, Marlette, Marrero, Marshalltown, Martinez, Marysville, Mattoon, Meadowbrook, Mechanicsville, Medford, Medina, Merced, Meridian, Metairie, Miami Beach, Midland, Midlothian, Milwaukee, Minneapolis, Minot, Missoula, Moline, Monticello, Moose Lake, Morristown, Mount Pleasant, Mount Sterling, Mount Vernon, Mukwonago, Mullica Hill, Murrells Inlet, Muskegon, Nags Head, Nampa, Napa, Neenah, New Albany, Newark, Newberg, New Brunswick, New London, New Orleans, New Richmond, Newton, New Ulm, New York, Niles, Norfolk, Normal, Norton Shores, Novi, Oakland, Oak Lawn, Ocean Pines, Oconomowoc, Oconto Falls, O'Fallon, Oklahoma City, Olney, Omaha, Ontario, Oregon City, Osage Beach, Oshkosh, Ottawa, Paducah, Pahrump, Papillion, Parker, Park Rapids, Park Ridge, Pekin, Pennington, Peoria, Pequot Lakes, Perrysburg, Peru, Phoenix, Phoenixville, Pine River, Pittsburg, Plant City, Pompton, Pontiac, Portland, Portsmouth, Port Townsend, Post Falls, Pottstown, Princeton, Providence, Pueblo, Racine, Raleigh, Rancho Mirage, Randallstown, Reading, Redmond, Reed City, Reno, Renton, Rhinelander, Richmond, Rio Rancho, Robbinsdale, Rockford, Rocklin, Rockport, Rolla, Royal Oak, Sacramento, Safety Harbor, Saginaw, Saint Cloud, Sainte Genevieve, Saint Joseph, Saint Louis Park, Saint Paul, Salisbury, San Antonio, Sandpoint, Sandstone, Sanford, San Luis Obispo, Santa Cruz, Santa Maria, Santa Rosa, Savannah, Scarborough, Seattle, Sedro-Woolley, Shakopee, Shawano, Sheboygan, Shelton, Sheridan, Silverdale, Sioux Falls, Southfield, South Portland, Spartanburg, Spokane, Spooner, Springfield, Staples, Sterling Heights, Stevens Point, St. Helena, Stillwater, St Louis, Stockton, Stony Brook, St. Petersburg, Sturgeon Bay, Sullivan, Summit, Superior, Tacoma, Tampa, Tawas City, Thief River Falls, Thornton, Tifton, Toledo, Topeka, Towson, Traverse City, Troy, Twin Falls, Two Rivers, Union, Urbana, Vancouver, Vineland, Virginia, Virginia Beach, Waconia, Walla Walla, Walnut Creek, Warren, Warwick, Washington, Washington D.C., Waukee, Waukesha, Waupaca, Wausau, Wauwatosa, Weaverville, West Allis, West Bloomfield, West Branch, West Columbia, West Des Moines, Westerville, West Haven, Westminster, West Reading, Wichita, Wilkes-Barre, Willmar, Wilmington, Winter Haven, Wisconsin Rapids, Woodbury, Woodland, Worthington, Wyandotte, Wyoming, Yakima, Yelm, Yorkville, Youngstown, Ypsilanti, Zanesville
- Age
- 40 years to 75 years
- People
- 2,900
- Run by
- Alliance for Clinical Trials in Oncology
See details and how to joinNCT05334069 - Phase 3Taking peopleA Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
- Where
- Annapolis, Baltimore, Burbank, Charlotte, Cleveland, Detroit, Durham, East Brunswick, Edmonds, Everett, Florham Park, Fort Worth, Germantown, Goodyear, Grand Island, Grand Rapids, Greenville, Irvine, Jacksonville, Kansas City, La Jolla, Lexington, Long Beach, Los Alamitos, Los Angeles, Louisville, Marietta, Mayfield Heights, Minneapolis, Nashville, New York, O'Fallon, Omaha, Palo Alto, Phoenix, Pittsburgh, Portland, Salt Lake City, San Marcos, San Mateo, Seattle, Shirley, Spring, Springfield, Sunnyvale, Tacoma, Tallahassee, Tampa, The Bronx, Urbana, Weston, Winston-Salem, Zion
- Age
- 18 years and over
- People
- 450 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06790693 · EU 2024-516162-11-00 - Phase 1Taking peopleClinical Trial of Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy
- Where
- San Antonio
- Age
- 18 years and over
- People
- 35
- Run by
- The University of Texas Health Science Center at San Antonio
See details and how to joinNCT07137871 - Phase 3Taking peopleA Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Where
- Abilene, Akron, Albany, Altamonte Springs, Anchorage, Appleton, Asheville, Athens, Baton Rouge, Baytown, Bethesda, Bethlehem, Boston, Brooklyn, Burlington, Canton, Cary, Chandler, Chapel Hill, Charleston, Cherry Hill, Chicago, Clermont, Cleveland, Clovis, Columbus, Coral Springs, Corvallis, Dallas, Duarte, Edgewood, Edmonds, El Paso, Emeryville, Eugene, Evanston, Everett, Fairfax, Fargo, Farmington, Fort Collins, Fort Myers, Frederick, Grand Junction, Greeley, Greenbrae, Honolulu, Hot Springs, Houston, Indianapolis, Iowa City, Irvine, Jacksonville, Kansas City, Lancaster, Lebanon, Lisle, Los Angeles, Loveland, Macon, Mayfield Heights, McAllen, Miami, Minneapolis, Nashville, Newburgh, Newnan, Newport Beach, New York, Oakland, Oceanside, Orange, Orange City, Orlando, Palm Springs, Palo Alto, Philadelphia, Phoenix, Portland, Renton, Rochester, Roseville, Saint Louis Park, Salt Lake City, San Antonio, San Francisco, Santa Clara, Santa Monica, Santa Rosa, Savannah, Seattle, Sewell, Sioux Falls, Spokane, Spokane Valley, Springdale, Springfield, Sterling Heights, Summit, Tacoma, Tampa, The Woodlands, Tucson, Tupelo, Vallejo, Walnut Creek, Washington D.C., Webster, Westbrook, Willow Grove, Wilson, Worcester, Yakima
- Age
- 18 years and over
- People
- 800 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07174336 · EU 2025-522791-92-00 - Phase 1Taking peopleImmune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer
- Where
- Duarte
- Age
- 18 years and over
- People
- 24
- Run by
- City of Hope Medical Center
See details and how to joinNCT06130826 - Phase 3Taking peopleA Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
- Where
- Albuquerque, Altamonte Springs, Charlotte, Cincinnati, Dallas, Daphne, Fort Worth, Grand Junction, Hackensack, Houston, Jamaica, Lexington, Los Angeles, Madison, McAllen, Nashville, Newark, New Brunswick, Newport Beach, Norfolk, Pittsburgh, Reno, Rio Rancho, San Antonio, St. Petersburg, Tacoma, Tucson, Westbury, Winchester, Winston-Salem, York
- Age
- 18 years and over
- People
- 1,000 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07060807 · EU 2025-520582-51-00 - Phase 2Taking peopleTo Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer
- Where
- East Brunswick, Jacksonville, Kansas City, Los Angeles
- Age
- 18 years and over
- People
- 80 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07368998 · EU 2025-522805-39-00 - Phase 2Taking peopleA Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
- Where
- Aberdeen, Anaheim, Jacksonville, Jamaica, Marshall, Milwaukee, Mitchell, Palo Alto, Pierre, Sioux Falls, Yankton
- Age
- 18 years and over
- People
- 80 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07405801 · EU 2025-523013-28-00 - Phase 1Taking peopleA Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer
- Where
- Boston, Fairfax, Nashville, New Haven, San Antonio, Sarasota
- Age
- 18 years and over
- People
- 170 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07524855 · EU 2026-527749-23-00 - Phase 1Taking peopleStudy of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer
- Where
- Dallas, Kansas City, New Haven
- Age
- 18 years and over
- People
- 194 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07604571 - Phase 3Taking peopleThe CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
- Where
- Albemarle, Albuquerque, Atlanta, Augusta, Aurora, Bellevue, Bluffton, Bonney Lake, Boston, Brewer, Chandler, Charlotte, Cincinnati, Concord, Crown Point, Denver, Derby, Dyer, Englewood, Eureka, Fairfield, Federal Way, Forest City, Foxborough, Gastonia, Gig Harbor, Gilbert, Glastonbury, Glendale, Goodyear, Greenwich, Guilford, Hartford, Highlands Ranch, Hilton Head Island, Hinesville, Hobart, Huntersville, Kirkland, Lancaster, Las Cruces, Lincolnton, Londonderry, Matthews, Memphis, Mesa, Methuen, Miami, Milford, Monroe, Munster, New Haven, Newton, North Haven, Olympia, Pembroke, Pennington, Philadelphia, Philidelphia, Phoenix, Plainsboro, Plantation, Puyallup, Rio Rancho, Rock Hill, Santa Rosa, Savannah, Scottsdale, Seattle, Shelby, Statesboro, Tacoma, Torrington, Trumbull, Valparaiso, Waterbury, Waterford, West Chester, Westerly, Westwood, Weymouth
- Age
- 60 years and over
- People
- 500
- Run by
- American Society of Clinical Oncology
See details and how to joinNCT06377852 - Phase 2Taking peopleA Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer
- Where
- Seattle
- Age
- 18 years and over
- People
- 40
- Run by
- University of Washington
See details and how to joinNCT07112053 - Phase 1Taking peopleStudy of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
- Where
- Fairfax, Houston, Los Angeles, Pittsburgh, San Antonio
- Age
- 18 years and over
- People
- 63
- Run by
- Regor Pharmaceuticals Inc.
See details and how to joinNCT07524322 - Phase 2Not yet taking people in United StatesTrastuzumab Deruxtecan and Lovastatin in HER2-low and Ultralow Advanced or Metastatic Breast Cancer
- Where
- St Louis
- Age
- 18 years and over
- People
- 60
- Run by
- Washington University School of Medicine
See details and how to joinNCT07619365 - Phase 1/2Taking peopleIvermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer and HR+/HER2- Metastatic Breast Cancer
- Where
- Los Angeles
- Age
- 18 years and over
- People
- 34
- Run by
- Yuan Yuan
See details and how to joinNCT05318469